| 852 | A | 086826 | 002 | THEOPHYLLINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | ELIXOPHYLLIN SR | FOREST LABS | 250MG | | [] | 1985-01-29 | Jan 29, 1985 | No | No | No | DISCN | FOREST LABORATORIES INC | 8f5ec7d0c18a6e4534a5532e65b7c3a6baf332dae574954f8848183949a1b404 |
| 853 | N | 022321 | 001 | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | EMBEDA | ALPHARMA PHARMS | 20MG;0.8MG | | [] | 2009-08-13 | Aug 13, 2009 | No | Yes | No | DISCN | ALPHARMA PHARMACEUTICALS LLC | 00295d036a5ccf3ce396b5314a2bde339f08e31472c10b8b7fe388758b7f135e |
| 854 | N | 022321 | 002 | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | EMBEDA | ALPHARMA PHARMS | 30MG;1.2MG | | [] | 2009-08-13 | Aug 13, 2009 | No | Yes | No | DISCN | ALPHARMA PHARMACEUTICALS LLC | 7b7dca7164101362c0420d55d87570453b2ed7ffc13bce8c98bbbbce2fe4597d |
| 855 | N | 022321 | 003 | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | EMBEDA | ALPHARMA PHARMS | 50MG;2MG | | [] | 2009-08-13 | Aug 13, 2009 | No | Yes | No | DISCN | ALPHARMA PHARMACEUTICALS LLC | 8a805bf74549028892280d791c478328ab98f665edbf71c77fed1e7377843ad2 |
| 856 | N | 022321 | 004 | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | EMBEDA | ALPHARMA PHARMS | 60MG;2.4MG | | [] | 2009-08-13 | Aug 13, 2009 | No | Yes | No | DISCN | ALPHARMA PHARMACEUTICALS LLC | 9cec45e1ceaa0064f1ed9d5e1aa6a6dbf55ccdde6fbcdcac7ae7af99fdc81a66 |
| 857 | N | 022321 | 005 | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | EMBEDA | ALPHARMA PHARMS | 80MG;3.2MG | | [] | 2009-08-13 | Aug 13, 2009 | No | Yes | No | DISCN | ALPHARMA PHARMACEUTICALS LLC | a09dfff46949f0976edcf6a82922698af039840b6fba8600f4d93dbb9e2a6eb2 |
| 858 | N | 022321 | 006 | MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | EMBEDA | ALPHARMA PHARMS | 100MG;4MG | | [] | 2009-08-13 | Aug 13, 2009 | No | Yes | No | DISCN | ALPHARMA PHARMACEUTICALS LLC | afcf9aa2cafec2c072466a53777ab752479a641f204814c3c8ddbbb2f80736dc |
| 859 | N | 021710 | 001 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | EQUETRO | VALIDUS PHARMS | 100MG | | [] | 2004-12-10 | Dec 10, 2004 | No | Yes | No | RX | VALIDUS PHARMACEUTICALS LLC | a343d6bb9a4d8a11325626ddd711c22cfa76eb3fe19a2cdd84d77965d50eeb52 |
| 860 | N | 021710 | 002 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | EQUETRO | VALIDUS PHARMS | 200MG | | [] | 2004-12-10 | Dec 10, 2004 | No | Yes | No | RX | VALIDUS PHARMACEUTICALS LLC | 9f012426b55b6f117ea0de3cd5a472e2dcf41ce7f7d3fd3785bfc5eff926d9ab |
| 861 | N | 021710 | 003 | CARBAMAZEPINE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | EQUETRO | VALIDUS PHARMS | 300MG | | [] | 2004-12-10 | Dec 10, 2004 | No | Yes | Yes | RX | VALIDUS PHARMACEUTICALS LLC | 7fdecc1ccc0b9119d0fd11aad919bd1814ba1e7a5ea02522a327de8d9a83e796 |
| 862 | N | 204168 | 001 | LEVOMILNACIPRAN HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FETZIMA | ALLERGAN | EQ 20MG BASE | AB | ["AB"] | 2013-07-25 | Jul 25, 2013 | No | Yes | No | RX | ALLERGAN SALES LLC | bd03f3400a2f49a17b8dee181569ebe5f6f9416be13d8e66af6d6fab5287a24d |
| 863 | N | 204168 | 002 | LEVOMILNACIPRAN HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FETZIMA | ALLERGAN | EQ 40MG BASE | AB | ["AB"] | 2013-07-25 | Jul 25, 2013 | No | Yes | No | RX | ALLERGAN SALES LLC | 2aa6acc7669e0011b24de014f7e75b2d27a34e6986af354890e70e6bf3a1b13f |
| 864 | N | 204168 | 003 | LEVOMILNACIPRAN HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FETZIMA | ALLERGAN | EQ 80MG BASE | AB | ["AB"] | 2013-07-25 | Jul 25, 2013 | No | Yes | No | RX | ALLERGAN SALES LLC | d2a6e64be8c47f1e86ab7f71226a2bdc1add7df1ed5c3dd7f2615fdd78495ff7 |
| 865 | N | 204168 | 004 | LEVOMILNACIPRAN HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FETZIMA | ALLERGAN | EQ 120MG BASE | AB | ["AB"] | 2013-07-25 | Jul 25, 2013 | No | Yes | Yes | RX | ALLERGAN SALES LLC | 81ded6712dd03ae8ee7ad14ff5a3d018603a53c70ef290120b1aad7bc6fff60f |
| 866 | A | 091482 | 001 | FLUVOXAMINE MALEATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FLUVOXAMINE MALEATE | ACTAVIS ELIZABETH | 100MG | AB | ["AB"] | 2013-04-23 | Apr 23, 2013 | No | No | No | RX | ACTAVIS ELIZABETH LLC | 2430dba8d390bfd74a7f15b21d11efbd7dafb7a1ba82bf96819b4b14368fbeff |
| 867 | A | 091482 | 002 | FLUVOXAMINE MALEATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FLUVOXAMINE MALEATE | ACTAVIS ELIZABETH | 150MG | AB | ["AB"] | 2013-11-18 | Nov 18, 2013 | No | No | Yes | RX | ACTAVIS ELIZABETH LLC | cdae62d2d9809ba052259553d5a2f55e660c9ce1a35c0297223f5f96a41c7659 |
| 868 | A | 091476 | 001 | FLUVOXAMINE MALEATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FLUVOXAMINE MALEATE | ANCHEN PHARMS | 100MG | AB | ["AB"] | 2013-03-13 | Mar 13, 2013 | No | No | No | RX | ANCHEN PHARMACEUTICALS INC | 5037b6c72b79fd5f2aabd8e7e5cb83dbe4c5e2a859490b09432828969e3851ed |
| 869 | A | 091476 | 002 | FLUVOXAMINE MALEATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FLUVOXAMINE MALEATE | ANCHEN PHARMS | 150MG | AB | ["AB"] | 2013-03-13 | Mar 13, 2013 | No | No | No | RX | ANCHEN PHARMACEUTICALS INC | 3b57d0cc29f48b38e444c7620cf3f48a08ddbeab46b36307b3c6cd7e5a13433c |
| 870 | A | 212182 | 002 | FLUVOXAMINE MALEATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FLUVOXAMINE MALEATE | BIONPHARMA INC | 100MG | | [] | 2020-09-16 | Sep 16, 2020 | No | No | No | DISCN | BIONPHARMA INC | 0b9683ca841720093115f4914b96e6f7e440d2e4f8f69e25ad1120514d1dd800 |
| 871 | A | 212182 | 001 | FLUVOXAMINE MALEATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FLUVOXAMINE MALEATE | BIONPHARMA INC | 150MG | AB | ["AB"] | 2020-05-11 | May 11, 2020 | No | No | No | RX | BIONPHARMA INC | a9f87dde4fb7bd530bf647307fadf2de1ccaf3af9c322ef81edf44a3749333b3 |
| 872 | A | 203240 | 001 | FLUVOXAMINE MALEATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FLUVOXAMINE MALEATE | TORRENT | 100MG | | [] | 2014-10-31 | Oct 31, 2014 | No | No | No | DISCN | TORRENT PHARMACEUTICALS LTD | 0d01efc728ab27a6dd90cd505d6b7801752b2afb5aa9c381ec7f94ac26126806 |
| 873 | A | 203240 | 002 | FLUVOXAMINE MALEATE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FLUVOXAMINE MALEATE | TORRENT | 150MG | | [] | 2014-10-31 | Oct 31, 2014 | No | No | No | DISCN | TORRENT PHARMACEUTICALS LTD | 2a1e07c4a6935119c2be24720ffcb080d566c7df61ac02006ca9822c83603f6d |
| 874 | N | 021802 | 001 | DEXMETHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FOCALIN XR | NOVARTIS | 5MG | AB | ["AB"] | 2005-05-26 | May 26, 2005 | No | Yes | No | RX | NOVARTIS PHARMACEUTICALS CORP | a27808d76d0f4225134cd96bd768f3f30cd3f2348249502b4c10f305da85dc95 |
| 875 | N | 021802 | 002 | DEXMETHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FOCALIN XR | NOVARTIS | 10MG | AB | ["AB"] | 2005-05-26 | May 26, 2005 | No | Yes | No | RX | NOVARTIS PHARMACEUTICALS CORP | 443dbec9c0e2b12494d94a24607599a40acad62cd83ed8f15aac45d6e0f46ef1 |
| 876 | N | 021802 | 004 | DEXMETHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FOCALIN XR | NOVARTIS | 15MG | AB | ["AB"] | 2006-08-01 | Aug 1, 2006 | No | Yes | No | RX | NOVARTIS PHARMACEUTICALS CORP | 138243e8797edab7d358c820d394e1cde68ff6c17e0cb7bb2865e15b2e590136 |
| 877 | N | 021802 | 003 | DEXMETHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FOCALIN XR | NOVARTIS | 20MG | AB | ["AB"] | 2005-05-26 | May 26, 2005 | No | Yes | No | RX | NOVARTIS PHARMACEUTICALS CORP | 32003efa165a80ed1b8bc600ad5f34a28d39ac2c3543e0d85268a2454317d5f4 |
| 878 | N | 021802 | 008 | DEXMETHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FOCALIN XR | NOVARTIS | 25MG | AB | ["AB"] | 2011-04-21 | Apr 21, 2011 | No | Yes | No | RX | NOVARTIS PHARMACEUTICALS CORP | 2c378b60176dcf9697d871a84f364dce4177a66d3d7341a4c3d3b695add0f884 |
| 879 | N | 021802 | 005 | DEXMETHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FOCALIN XR | NOVARTIS | 30MG | AB | ["AB"] | 2009-10-23 | Oct 23, 2009 | No | Yes | No | RX | NOVARTIS PHARMACEUTICALS CORP | 94069872c56cc8d1f6f5ab2376dc8bdd2c53ca0fa0547d41e5454c10c7a7610c |
| 880 | N | 021802 | 007 | DEXMETHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FOCALIN XR | NOVARTIS | 35MG | AB | ["AB"] | 2011-04-21 | Apr 21, 2011 | No | Yes | No | RX | NOVARTIS PHARMACEUTICALS CORP | 5e095830c14ea110a6e931dab5af99ba2c67177199a03ba4e5e67d729f921d28 |
| 881 | N | 021802 | 006 | DEXMETHYLPHENIDATE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | FOCALIN XR | NOVARTIS | 40MG | AB | ["AB"] | 2010-08-11 | Aug 11, 2010 | No | Yes | Yes | RX | NOVARTIS PHARMACEUTICALS CORP | 58b0342371d452ff72e0311086ac85f628793a14ff0cb1c3be77ef8257bc6d32 |
| 882 | A | 204895 | 001 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | AUROBINDO PHARMA LTD | EQ 8MG BASE | AB | ["AB"] | 2016-08-05 | Aug 5, 2016 | No | No | No | RX | AUROBINDO PHARMA LTD | bb356355e8cf1d35a88072bd53d8bf5217e92c6f8c195ae8a2b28f5d99e6cefa |
| 883 | A | 204895 | 002 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | AUROBINDO PHARMA LTD | EQ 16MG BASE | AB | ["AB"] | 2016-08-05 | Aug 5, 2016 | No | No | No | RX | AUROBINDO PHARMA LTD | 4d152f8386f811d50d3548b966eebacaaa49f39c7ff7d8d65257dd31dda15320 |
| 884 | A | 204895 | 003 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | AUROBINDO PHARMA LTD | EQ 24MG BASE | AB | ["AB"] | 2016-08-05 | Aug 5, 2016 | No | No | No | RX | AUROBINDO PHARMA LTD | 4f0d464a0da73775ec7ed53a89f64b53c4506aa2d5a858dbbe887410b0ac1b3c |
| 885 | A | 078189 | 001 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | BARR | EQ 8MG BASE | AB | ["AB"] | 2008-09-15 | Sep 15, 2008 | No | No | No | RX | BARR LABORATORIES INC | f85dbe95e2239afaad0784848a2c0abfbef41ab731c34a33032c22da764c1ae4 |
| 886 | A | 078189 | 002 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | BARR | EQ 16MG BASE | AB | ["AB"] | 2008-09-15 | Sep 15, 2008 | No | No | No | RX | BARR LABORATORIES INC | ce6772f8a36401da5f87d51b835d007464deb77b340b3a61c6b45ee15fc970d2 |
| 887 | A | 078189 | 003 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | BARR | EQ 24MG BASE | AB | ["AB"] | 2008-09-15 | Sep 15, 2008 | No | No | No | RX | BARR LABORATORIES INC | 6504bf1ddfcff6f8711e1ceca4e64e87ecd29d26e8be03138b95e31d3a1b9b29 |
| 888 | A | 078484 | 001 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | IMPAX LABS | EQ 8MG BASE | | [] | 2009-05-27 | May 27, 2009 | No | No | No | DISCN | IMPAX LABORATORIES INC | 04251e7062e039beb17bd392c79b29c62b527f59ed80a60fd77ddc6768d8d95f |
| 889 | A | 078484 | 002 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | IMPAX LABS | EQ 16MG BASE | | [] | 2009-05-27 | May 27, 2009 | No | No | No | DISCN | IMPAX LABORATORIES INC | f263f417e4781fa6d196be4625f7089afad89ba01dc94c6404fcbfe52cb62b47 |
| 890 | A | 078484 | 003 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | IMPAX LABS | EQ 24MG BASE | | [] | 2009-05-27 | May 27, 2009 | No | No | No | DISCN | IMPAX LABORATORIES INC | 4fd69a8873cbba9215af7b1c5a5626e63e36f51efa15551bd29838cc39289f3d |
| 891 | A | 090900 | 001 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | MYLAN | EQ 8MG BASE | | [] | 2011-01-24 | Jan 24, 2011 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 54310e363cfc1faf60cdb5bde08e7792135aa1ba9a297571b9f024c1a5927c0c |
| 892 | A | 090900 | 002 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | MYLAN | EQ 16MG BASE | | [] | 2011-01-24 | Jan 24, 2011 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | da911deff57a1cef485a97a062086eab35cbefe5e107ac232b97b8d4f47edef6 |
| 893 | A | 090900 | 003 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | MYLAN | EQ 24MG BASE | | [] | 2011-01-24 | Jan 24, 2011 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 1906320e529c0b5b66e1663fc34e7074f4152ef192c7a2c9519d5e8a7fb0b710 |
| 894 | A | 090178 | 001 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | SUN PHARM | EQ 8MG BASE | AB | ["AB"] | 2011-02-02 | Feb 2, 2011 | No | No | No | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | 7973a306c17d3da4cecc5711c4afcceb68683f7e89cd79464a1917d9d7fb032f |
| 895 | A | 090178 | 002 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | SUN PHARM | EQ 16MG BASE | AB | ["AB"] | 2011-02-02 | Feb 2, 2011 | No | No | No | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | 93c4b47af02f471d2c25da41432ed02a7ee5a2f67bc6c82e3fa146d4fb67baa2 |
| 896 | A | 090178 | 003 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | SUN PHARM | EQ 24MG BASE | AB | ["AB"] | 2011-02-02 | Feb 2, 2011 | No | No | No | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | da947f62908aeba157013c90682532f27cb95bc2d7861a23e3b296bfb37f8ebd |
| 897 | A | 079028 | 001 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | WATSON LABS | EQ 8MG BASE | AB | ["AB"] | 2008-12-15 | Dec 15, 2008 | No | No | No | RX | WATSON LABORATORIES INC | 8463f7b5dfd755a9770cd807c7927c0f7bb831866a266bac6f35d0ceec314628 |
| 898 | A | 079028 | 002 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | WATSON LABS | EQ 16MG BASE | AB | ["AB"] | 2008-12-15 | Dec 15, 2008 | No | No | No | RX | WATSON LABORATORIES INC | e38d82f4399510b5e05cf7110090817e867494251722d4c88da1cdd1598e301f |
| 899 | A | 079028 | 003 | GALANTAMINE HYDROBROMIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GALANTAMINE HYDROBROMIDE | WATSON LABS | EQ 24MG BASE | AB | ["AB"] | 2008-12-15 | Dec 15, 2008 | No | No | No | RX | WATSON LABORATORIES INC | 1a90e2945153e9a78fce8d6758e61baca66b4e78b2a40decf242fadb1b7566f5 |
| 900 | N | 208944 | 001 | AMANTADINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GOCOVRI | ADAMAS PHARMA | EQ 68.5MG BASE | | [] | 2017-08-24 | Aug 24, 2017 | No | Yes | No | RX | ADAMAS PHARMA LLC | 58758e010debcaab0fab6a1731da81037a20bc1304ea791c881abd09b1b6fb69 |
| 901 | N | 208944 | 002 | AMANTADINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE;ORAL | CAPSULE, EXTENDED RELEASE | ORAL | GOCOVRI | ADAMAS PHARMA | EQ 137MG BASE | | [] | 2017-08-24 | Aug 24, 2017 | No | Yes | Yes | RX | ADAMAS PHARMA LLC | 124fcec8e32b99717daa36c7e30dc02f8aed2b41d94501d25a0c52761e195e42 |